Heart Disease

A “profile” of the genes and regulatory networks that govern early heart valve development lay the groundwork for generating valves from a patient’s own cells. Read More

Vanderbilt University scientists have discovered a potential new strategy for lowering cholesterol and triglyceride levels and stopping atherosclerosis and fatty liver disease. Read More

A genetic variant may help keep an individual’s “good” cholesterol in check. Read More

The Health Care Innovation Award from the Centers for Medicare and Medicaid Services (CMS) is one of the largest federal research grants awarded to VUMC investigators. The funding will support the implementation and evaluation of MyHealthTeam, a model of team-based care that couples collaborative health care teams with health information technology in order to improve control of chronic conditions. Read More

Heart disease is still the leading cause of death for men in Tennessee and cancer deaths continue to move further away from the Centers for Disease Control and Prevention’s Healthy People 2020 goal, according to the 2012 Tennessee Men’s Health Report Card. Read More

Vanderbilt University is already doing genetic analyses of patients to help in developing a shortlist of effective drugs, says Dr. William Schaffner, chairman of the department of preventive medicine at its medical school. Read More

Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol. Read More

Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis. Read More